Catel-Manzke syndrome is a rare genetic condition that affects facial and hand development. People with Catel-Manzke syndrome often have a small lower jaw, feeding or breathing difficulties in infancy, and an unusual bend in the index fingers. Features usually appear at birth and are lifelong, but the day-to-day impact can improve with growth and care. Treatment focuses on supportive care like feeding support, breathing management, dental and speech care, and hand therapy or surgery when needed. Not everyone will have the same experience, and with coordinated care many living with Catel-Manzke syndrome do well.
Overview
Catel-manzke syndromeSymptoms
Catel-Manzke syndrome shows up at birth with a small lower jaw, tongue falling back, and often a cleft palate, leading to feeding or breathing trouble. Hands typically have an extra small bone in the index finger, causing bending or overlap.
Outlook and prognosis
Most children with Catel-Manzke syndrome grow and learn, though feeding and breathing challenges early on may need support. Hand differences are lifelong but usually manageable with therapy, splints, or surgery. With coordinated care, many achieve good quality of life into adulthood.
Causes and risk factors
Catel-Manzke syndrome results from harmful changes in the TGDS gene, usually inherited in an autosomal recessive pattern. Risk rises when both parents are carriers, especially in consanguineous families. There are no known lifestyle or environmental causes.
Genetic influences
Genetics is central in Catel-Manzke syndrome. Most cases result from inherited variants in the TGDS gene, typically autosomal recessive, meaning both parents carry a silent change. Rarely, different genes or new (de novo) variants are involved.
Diagnosis
Doctors suspect Catel‑Manzke syndrome from characteristic facial and hand features. Genetic tests confirm the diagnosis, with imaging and specialist exams as needed. Early genetic diagnosis of Catel‑Manzke syndrome supports coordinated care.
Treatment and drugs
Treatment for Catel-Manzke syndrome focuses on each person’s needs. Care often includes feeding support for babies, airway and jaw management, hand therapy or surgery for finger positioning, hearing checks, and early developmental services. A coordinated team guides timing and choices.
Symptoms
In Catel‑Manzke syndrome, early features often show up in the face and hands. Parents often notice early features of Catel-Manzke syndrome at birth, mainly a small lower jaw, feeding or breathing trouble, and index fingers that angle toward the thumb. Features vary from person to person and can change over time.
A shorter-than-usual lower jaw can make the chin look small. This can crowd the tongue and narrow the space at the back of the mouth. In Catel-Manzke syndrome, this is present from birth.
The tongue can sit farther back and slip toward the throat, especially when lying on the back. Clinicians call this glossoptosis, which means the tongue’s position can partly block airflow. You may hear noisy breathing or brief pauses.
An opening in the roof of the mouth makes it hard to create suction during feeds. Milk may leak through the nose, and weight gain can be slow at first. Speech may sound nasal later in childhood.
Babies can tire during feeds and need frequent pauses to breathe. In Catel-Manzke syndrome, this often relates to the small jaw and cleft palate. Early months may bring slow weight gain until feeding becomes more efficient.
How people usually first notice Catel-manzke syndrome?
Families often notice the first signs of Catel‑Manzke syndrome at birth or soon after, when a baby has a small lower jaw and tongue that sits further back, which can make feeding or breathing tricky. Doctors may also see thumbs that angle toward the index fingers or seem “hooked,” prompting an exam and X‑rays of the hand. These early features usually lead to a genetics referral, where testing confirms the diagnosis and explains how Catel‑Manzke syndrome is first noticed in many newborns.
Types of Catel-manzke syndrome
Catel-Manzke syndrome is a rare genetic condition linked to a change in the TGDS gene. Most reports describe one main clinical pattern with small lower jaw, tongue falling back, feeding and breathing challenges in infancy, and extra finger-like bones near the index fingers. Clinicians often describe them in these categories: people with the “classic” form and those with milder or atypical presentations. Because it’s so rare, formal subtypes are limited, and types of Catel-Manzke syndrome are largely based on how strongly features show up rather than on distinct genetic variants.
Classic phenotype
Features often include a small lower jaw with breathing or feeding issues in infancy and extra bone segments near the index fingers. Growth may be small for age, and joints can feel loose. Some develop hearing issues or dental crowding as they grow.
Mild/atypical presentation
Core features are present but less pronounced, such as subtle jaw differences and mild hand changes that may be missed early on. Breathing and feeding troubles can be limited or improve quickly. School-age children may mainly show dental or speech concerns.
Severe early course
Newborns can have significant breathing and feeding problems that require support. Hand findings are clear at birth with noticeable index-finger deviation. Hospital stays can be longer during the first months of life.
What genetics can tell you about symptoms
Catel-Manzke syndrome often involves a small lower jaw, wide-spaced eyes, and finger bending toward the thumb, linked to variants in the TGDS gene that disrupt bone and cartilage development. Some families have maternally inherited variants causing milder facial features but similar finger changes.
Causes and risk factors
Catel-Manzke syndrome is usually caused by changes in a gene called TGDS.
The inheritance pattern of Catel-Manzke syndrome is autosomal recessive, which means a child is affected only if both parents pass on a nonworking copy.
Some risks are written in our DNA, passed down through families.
The main risk is having two carrier parents, and the chance is higher when parents are related by blood.
Lifestyle and environmental exposures do not cause it, but other genes and prenatal factors may shape how severe the features are.
Environmental and biological risk factors
Catel-Manzke syndrome is a rare condition present from birth. Many families focus on early symptoms of Catel-Manzke syndrome, but it’s also helpful to understand what might shape its chances of occurring. Doctors often group risks into internal (biological) and external (environmental).
The features form as the jaw and index finger develop in the first trimester. This points to internal developmental biology as the main driver rather than later-life environmental triggers.
Research has not found specific environmental exposures tied to Catel-Manzke syndrome. Published reports do not show a repeating pattern with toxins, pollutants, or infections.
Common pregnancy conditions such as diabetes or thyroid problems can affect fetal development in general, but they have not been shown to cause this syndrome. Current evidence does not support a consistent link.
Genetic risk factors
In families where a child has Catel-manzke syndrome, genetics are usually the driver. Most cases trace back to changes in a single gene called TGDS and follow an autosomal recessive pattern, meaning both parents silently carry one non-working copy. Some risk factors are inherited through our genes. Family history and shared ancestry can influence the chance of another child being affected.
TGDS gene changes: Variants in the TGDS gene cause Catel-manzke syndrome by altering early bone and soft‑tissue development. This gene helps guide how parts of the jaw, palate, and index fingers form.
Autosomal recessive inheritance: The condition appears when a child inherits two non‑working copies of TGDS, one from each parent. Parents who carry one changed copy usually have no symptoms.
Recurrence risk 25%: When both parents are carriers, each pregnancy has a 25% (1 in 4) chance of an affected child. There is also a 50% (1 in 2) chance the child will be an unaffected carrier.
Consanguinity factor: Parents who are related by blood have a higher chance of carrying the same rare TGDS variant. This can raise the likelihood of a child inheriting both altered copies.
Carrier relatives: Brothers, sisters, and extended family may be carriers if both parents carry a TGDS change. Carrier testing can clarify who in the family might pass the variant on.
Variable expressivity: Features can differ in type and severity even with the same TGDS variants. For some, early symptoms of Catel-manzke syndrome are more noticeable at birth, while others become clearer over time.
Lifestyle risk factors
Lifestyle habits do not cause Catel-manzke syndrome, but day-to-day routines can shape feeding safety, breathing, growth, and function. Understanding how lifestyle affects Catel-manzke syndrome can help families support care between clinic visits. Below are practical ways habits may influence symptoms and complications, framed as lifestyle risk factors for Catel-manzke syndrome.
Pacing, appropriate nipple flow, and safe-feeding posture can lower choking and aspiration risk linked to small jaw and palate issues. Calorie-dense, frequent feeds may support growth when feeding takes extra effort.
Airway-optimized sleep positioning recommended by your care team can reduce obstructive episodes at night. Consistent, restorative sleep can improve daytime feeding endurance and developmental progress.
Age-appropriate food textures and smaller, more frequent meals can curb reflux that worsens airway irritation and aspiration risk. Upright time after meals may further ease symptoms.
Meticulous brushing and fluoride use help prevent cavities and gum inflammation that can complicate feeding and speech after palate repair. Regular dental follow-up supports jaw and tooth alignment challenges common in this condition.
Risk prevention
Catel‑Manzke syndrome is a rare genetic condition, so you can’t prevent the syndrome itself, but you can lower the chance of complications and support healthy development. Planning ahead for birth and early infancy makes the biggest difference for breathing, feeding, and growth. Even if you can’t remove all risks, prevention can reduce their impact. Families may also consider genetic counseling to understand options for future pregnancies.
A genetics visit can explain inheritance, carrier testing, and options for future pregnancies. This may include prenatal testing or IVF with embryo testing to lower the chance of having another child with Catel‑Manzke syndrome.
Delivering at a center experienced with newborn airway issues can reduce emergencies. Having ENT and neonatal teams ready helps prevent breathing crises right after birth in Catel‑Manzke syndrome.
Side‑lying or tummy‑down positioning when supervised can help keep the tongue forward and airway open. This lowers the risk of low oxygen and hospital readmissions in babies with Catel‑Manzke syndrome.
Specialized bottles, paced feeds, and reflux care reduce choking, aspiration, and poor weight gain. Early symptoms of Catel‑Manzke syndrome often include feeding trouble, so prompt support helps prevent complications.
Transmission
Catel-Manzke syndrome is a genetic condition, not an infection—you can’t catch it or spread it through everyday contact. It is most often inherited in an autosomal recessive pattern, meaning a child is affected only if they receive two nonworking copies of the same gene, one from each parent, who are typically healthy carriers. When both parents are carriers, each pregnancy has a 25% chance of a child with Catel-Manzke syndrome, a 50% chance of a child who is a healthy carrier, and a 25% chance of a child who inherits neither change. If you’re wondering how Catel-Manzke syndrome is inherited, genetic counseling and testing can help clarify carrier status and the chance of recurrence in future pregnancies.
When to test your genes
Consider genetic testing if a child shows features of Catel-Manzke syndrome—hand abnormalities with “extra” finger-like bones and facial differences—or if a close relative is diagnosed. Testing helps confirm the cause, guide care plans, and inform future pregnancies. Prenatal or preimplantation testing may be options for families with a known variant.
Diagnosis
Families usually first notice breathing or feeding struggles in a newborn with a very small lower jaw and curved index fingers that don’t straighten fully. Getting a diagnosis is often a turning point toward answers and support. For many, the genetic diagnosis of Catel-manzke syndrome is based on these recognizable features and then confirmed by targeted genetic testing.
Doctors usually begin with a head-to-toe exam looking for a small lower jaw, tongue that falls back, and a cleft palate. Curved index fingers with limited straightening raise suspicion for Catel-manzke syndrome. Together, these patterns guide next tests.
Simple X-rays of the hands can show an extra or misshapen small bone in the index finger. This imaging finding helps distinguish Catel-manzke syndrome from other conditions with a similar facial pattern. It’s a key clinical clue in newborns and infants.
A blood or saliva test can look for changes in the TGDS gene, which confirms the diagnosis. Testing may be done as a single-gene test or as part of a craniofacial or skeletal panel. Confirmation helps with care planning and clarifies recurrence risk for future pregnancies.
A detailed family and health history can help identify relatives with small jaws, cleft palate, or similar finger findings. Most cases are rare and occur when both parents carry a non-working copy of the same gene. This information guides who else in the family may benefit from counseling or testing.
Stages of Catel-manzke syndrome
Catel-manzke syndrome does not have defined progression stages. It’s a congenital condition present from birth, and while early symptoms of Catel-manzke syndrome—such as breathing or feeding trouble from a small lower jaw and a distinctive index finger shape—can change as a child grows or after surgery, the condition doesn’t follow a stepwise decline. Doctors usually start with a conversation about your child’s birth history, feeding and breathing, then examine the hands and jaw, sometimes using X-rays to look at the finger bones. Genetic testing may be offered to clarify certain risks and confirm the diagnosis, and ongoing monitoring focuses on airway, growth, speech, and hand function.
Outlook and prognosis
Looking at the long-term picture can be helpful. For most people with Catel-Manzke syndrome, life expectancy is near normal, especially when heart, breathing, and feeding issues are identified early and managed well. The biggest health risks usually occur in infancy and early childhood, when airway blockage from a small lower jaw, trouble gaining weight, or heart differences may require close monitoring or surgery. Early symptoms of Catel-Manzke syndrome that influence outlook often include breathing pauses during sleep, feeding fatigue, and recurrent ear infections; when these are addressed, children typically grow, learn, and participate in daily life with appropriate supports.
Over time, most people with Catel-Manzke syndrome see facial and jaw features become less pronounced as the face grows, though hand differences generally remain. Development is often typical or mildly delayed, and many children attend mainstream school with therapies for speech or fine motor skills. Serious complications are uncommon after the early years, but sleep apnea, dental crowding, and hearing issues can persist and may need ongoing care. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
The outlook is not the same for everyone, but most published reports do not show increased mortality beyond early childhood when care is available. If major heart or airway problems are present and untreated, risks are higher, which is why early, coordinated care with ENT, cardiology, feeding, and dental teams matters. Families often want to know what role they can play, and staying on top of hearing checks, dental visits, sleep evaluations, and therapy appointments can help maintain health and independence. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Catel-Manzke syndrome tends to show its effects most clearly in infancy and early childhood, then settles into a more predictable pattern as children grow. Long-term effects vary widely, and not every child will experience the same set of challenges. Parents often first notice features that are sometimes called early symptoms of Catel-Manzke syndrome in the newborn period, mainly related to breathing, feeding, and the small lower jaw. Over time, many children do well, though some features—like finger shape or palate-related speech differences—can persist into adulthood.
Airway blockage from a small lower jaw and tongue position can cause noisy breathing or pauses, especially when lying on the back. This often eases as the jaw grows, though some develop sleep apnea later.
Early feeding can be slow or tiring, with episodes of choking or poor weight gain. As the mouth and jaw mature, feeding typically becomes easier and growth patterns stabilize.
A cleft or high-arched palate can lead to nasal-sounding speech and articulation differences. Speech clarity often improves with growth and care plans tailored to palate anatomy in Catel-Manzke syndrome.
Repeated middle-ear fluid can cause temporary or fluctuating conductive hearing loss. Some children have long stretches of normal hearing between episodes.
How is it to live with Catel-manzke syndrome?
Living with Catel-Manzke syndrome often means juggling feeding challenges in infancy, speech delays, and frequent visits for airway, hearing, dental, and orthopedic care, especially for thumb and jaw differences. Many children need early support such as specialized bottles, speech and occupational therapy, and sometimes surgery; with these in place, most families find a steady routine and children make meaningful developmental progress. Day to day, parents and caregivers coordinate therapies, schools, and specialists, while friends and relatives can help by learning safe feeding positions, encouraging clear communication, and celebrating small gains. Over time, community—therapists, teachers, extended family—becomes part of the team, easing stress and helping the child build confidence and independence.
Treatment and drugs
Treatment for Catel-Manzke syndrome focuses on easing symptoms and supporting feeding, breathing, growth, and movement. Care teams often include pediatrics, ENT, cardiology, orthopedics, genetics, speech and feeding therapy, and physiotherapy, and treatment plans often combine several approaches. Babies may need help with feeding, positioning, and sometimes a temporary feeding tube; breathing support or surgery can be considered if a small lower jaw or tongue position causes airway blockage. Hand and joint differences are usually managed with splints, physical and occupational therapy, and, in select cases, surgery to improve function. Although living with Catel-Manzke syndrome can feel overwhelming, supportive care can make a real difference in how you feel day to day.
Non-drug treatment
Non-drug care focuses on breathing, feeding, growth, and movement so daily life feels safer and more manageable for families. Catel-manzke syndrome often needs coordinated support from speech, nutrition, ENT, and therapy teams starting in infancy. Non-drug treatments often lay the foundation for long-term health and reduce the need for emergency care. Plans are tailored to each child’s features and change as needs evolve.
Early symptoms of Catel-manzke syndrome, like slow feeds or coughing with bottles, can signal the need for special nipples or pacing. A feeding therapist can show positions that protect the airway and improve intake. Some babies benefit from thickened liquids or temporary tube feeds.
Care teams teach side-lying or tummy-lying positions that ease tongue blockage and support calmer breathing. For some with Catel-manzke syndrome, a soft nasal tube (nasopharyngeal airway) can help keep the airway open. Nighttime monitoring may be used to check oxygen levels.
A custom mouth plate can seal a cleft gap, making sucking easier and reducing milk going into the nose. These devices can also guide jaw and gum shape before later procedures. Regular adjustments keep the fit comfortable as a child grows.
Early work on feeding and oral-motor skills can help set the stage for later speech. As children grow, therapy targets sound production and resonance after cleft repair plans. Parents learn home exercises to reinforce progress.
Your genes may have an impact on how drugs work for you
Medicines used in Catel-Manzke syndrome can act differently depending on genes that affect how the body absorbs, breaks down, and clears drugs. Pharmacogenetic testing may guide doses for pain control, anesthesia, or infection treatment, improving benefit while reducing side effects.
Pharmacological treatments
Medicines for Catel‑Manzke syndrome focus on easing day‑to‑day issues like reflux, pain, ear infections, or heart‑related symptoms when present. Drugs that target symptoms directly are called symptomatic treatments. Some medicines are used early to reduce feeding discomfort or breathing strain tied to early symptoms of Catel‑Manzke syndrome. Your care team will match treatments to your child’s age, symptoms, and any related conditions.
Omeprazole or lansoprazole can lower stomach acid and ease reflux-related discomfort that makes feeding harder. Famotidine can be an alternative if proton pump inhibitors aren’t a fit. Doctors reassess need as airway and feeding improve.
Acetaminophen or ibuprofen can reduce pain after procedures or with ear infections. Doses are based on weight, and ibuprofen may be avoided in young infants per local guidance. Never combine multiple acetaminophen-containing products.
Amoxicillin is often the first choice for acute middle-ear infections. Amoxicillin–clavulanate or cefdinir may be used if symptoms persist or with certain allergies. Treating infections can support hearing and speech development.
If a heart defect causes fluid buildup, furosemide can reduce swelling and ease breathing. Some children may also receive captopril or enalapril, and sometimes spironolactone, under cardiology care. These drugs are used only when heart-related symptoms are present.
Genetic influences
Many families ask whether Catel‑Manzke syndrome is inherited; in most cases, it is. Changes in both copies of a single gene called TGDS lead to the condition, a pattern known as autosomal recessive. This means parents are usually healthy carriers and each child has a 25% (1 in 4) chance of having the condition if both parents carry the same gene change. A “carrier” means you hold the gene change but may not show symptoms. Genetic testing can look for TGDS changes to confirm the diagnosis and to check who in the family carries the variant. If relatives are planning a pregnancy, carrier screening, prenatal testing, or IVF with embryo testing may be options to consider with a genetic counselor, and genetic testing for Catel‑Manzke syndrome can help guide those discussions.
Is Catel-manzke syndrome genetic?
Genetics is central in Catel-Manzke syndrome. Most cases result from inherited variants in the TGDS gene, typically autosomal recessive, meaning both parents carry a silent change. Rarely, different genes or new (de novo) variants are involved.
Pharmacogenetics—how genetics influence drug effects
For people with Catel‑Manzke syndrome, medicines are used mainly around surgeries and to manage issues like pain, reflux, and infections, so safety and dosing are tailored with the airway and feeding needs in mind. The syndrome is usually caused by changes in a gene called TGDS; this doesn’t, by itself, point to a specific drug or dose, so there aren’t syndrome‑specific drug–gene rules yet. Genes can influence how quickly you activate or clear some pain medicines such as codeine or tramadol, so teams often avoid codeine in children and anyone with breathing risks, or use non‑opioid options and, when needed, adjust plans based on a common liver‑enzyme gene (CYP2D6). If a reflux medicine like a proton pump inhibitor is used, differences in another enzyme (CYP2C19) can affect how well it works, which may lead to a different dose or a different choice within the same drug family. Anesthesia is planned carefully because a small jaw and narrow airway can make sedatives and opioids more risky; if there’s a personal or family history of unusually long paralysis after surgery, doctors may check for a rare enzyme problem before using certain muscle relaxants. Beyond genes, age, weight, other conditions, and past surgeries also guide medication choices, so talk with your care team about whether medication response in Catel‑Manzke syndrome could benefit from targeted genetic testing, especially if pain control has been difficult or past drugs caused unexpected side effects.
Interactions with other conditions
Breathing and feeding challenges in Catel-Manzke syndrome can interact with other illnesses in day-to-day life, especially during infancy and childhood. Doctors call it a “comorbidity” when two conditions occur together. Colds, bronchiolitis, or other respiratory infections can make existing airway narrowing from a small lower jaw and cleft palate worse, sometimes leading to more noisy breathing, pauses in breathing, or trouble maintaining weight. Reflux and swallowing discoordination can add to this, raising the risk of choking or chest infections and making feeds more stressful. Because a cleft palate can affect how the ears drain, frequent ear infections and temporary hearing loss may occur; this can influence speech development and may require closer coordination between ear, nose, and throat care and speech therapy. Some children also have heart differences, which can change anesthesia planning and the timing of cleft or airway surgeries. While finger and hand differences themselves rarely interact with other diseases, occupational therapy plans may be adjusted if there are additional neuromuscular or developmental concerns. In practice, the most relevant comorbidities of Catel-Manzke syndrome tend to be respiratory infections, ear problems, reflux, and—less often—heart conditions, and treating them together usually leads to smoother progress.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described infants with unusually bent index fingers and small lower jaws who had trouble feeding and gaining weight. Families and midwives noticed that some babies needed creative positioning to breathe or nurse, and that these traits sometimes showed up in more than one child. Later, careful pediatric notes linked the hand shape with a tiny chin and a high-arched or cleft palate, patterns that helped clinicians recognize what is now called Catel‑Manzke syndrome.
First described in the medical literature as a pairing of a distinctive index finger curve with features of Pierre Robin sequence, early reports focused on how newborns struggled with airway blockage and feeding. Doctors documented the outward features they could see and the day‑to‑day challenges parents faced, like long feeding times, frequent pauses for breathing, and the need for special bottles. Over time, descriptions became more precise, and photos and hand X‑rays helped define the characteristic “extra” bone segment in the index finger that bends the finger toward the thumb.
As medical science evolved, specialists noticed that growth and development could vary widely. Some children with Catel‑Manzke syndrome grew well after early feeding support, while others needed surgeries for the palate or jaw. Cardiologists and orthopedists added that a minority had heart or skeletal differences, expanding the clinical picture beyond the mouth and hands. These historical steps guided practical care: securing the airway safely, supporting feeding and speech, and monitoring for other features without assuming they would happen to everyone.
Advances in genetics eventually clarified the underlying cause. Mapping studies and family reports pointed to an inherited pattern in some lineages, and DNA research now explains that changes in a specific gene involved in building connective tissues can lead to the hand and jaw findings seen in Catel‑Manzke syndrome. This shift—from describing what doctors saw to understanding why it happens—allowed more accurate diagnosis, genetic counseling, and the option of testing when it’s helpful for care planning.
In recent decades, awareness has grown as neonatal teams, speech therapists, and hand surgeons have shared experience. Case series from different countries showed that early symptoms of Catel‑Manzke syndrome often center on feeding and breathing, while later childhood may focus on dental care, speech therapy, and hand function. Not every early description was complete, yet together they built the foundation of today’s knowledge. Looking back helps explain why care now emphasizes early airway and feeding support, coordinated follow‑up, and family counseling rooted in both clinical experience and genetic insight.